STRS OHIO - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 191 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
STRS OHIO ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$45
-6.2%
8,700
-5.4%
0.00%
Q4 2023$48
-66.9%
9,2000.0%0.00%
-100.0%
Q3 2023$145
-99.9%
9,200
+217.2%
0.00%0.0%
Q2 2022$128,000
-72.2%
2,900
-68.8%
0.00%
-50.0%
Q1 2022$460,000
+586.6%
9,300
+481.2%
0.00%
Q3 2020$67,000
-88.5%
1,600
-86.9%
0.00%
-100.0%
Q2 2020$585,000
+7.9%
12,200
+3.4%
0.00%0.0%
Q1 2020$542,000
-20.8%
11,800
+3.5%
0.00%0.0%
Q4 2019$684,000
-47.9%
11,400
-50.9%
0.00%0.0%
Q3 2019$1,312,000
+90.1%
23,200
+87.1%
0.00%0.0%
Q2 2019$690,000
+15.0%
12,400
+4.2%
0.00%0.0%
Q1 2019$600,000
+25.3%
11,9000.0%0.00%
+50.0%
Q4 2018$479,000
-41.9%
11,9000.0%0.00%
-50.0%
Q3 2018$825,000
-8.3%
11,9000.0%0.00%0.0%
Q2 2018$900,000
+757.1%
11,900
+495.0%
0.00%
Q1 2018$105,000
-18.0%
2,000
-16.7%
0.00%
-100.0%
Q4 2017$128,000
-82.8%
2,400
-80.8%
0.00%
-66.7%
Q3 2017$745,000
+1.6%
12,500
+34.4%
0.00%0.0%
Q2 2017$733,000
+10.6%
9,300
+16.2%
0.00%0.0%
Q1 2017$663,000
+168.4%
8,000
+31.1%
0.00%
+200.0%
Q1 2016$247,000
-66.8%
6,100
-27.4%
0.00%
-66.7%
Q4 2015$744,000
+2.6%
8,400
-14.3%
0.00%0.0%
Q3 2015$725,000
-8.5%
9,8000.0%0.00%0.0%
Q2 2015$792,0009,8000.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Hudson Executive Capital LP 1,323,794$79,534,0003.54%
Park West Asset Management LLC 1,171,880$70,406,0002.96%
Matarin Capital Management, LLC 170,008$10,214,0000.98%
Smith, Graham & Co., Investment Advisors, LP 140,014$8,412,0000.82%
Capital Impact Advisors, LLC 33,725$2,026,0000.71%
U S GLOBAL INVESTORS INC 18,800$1,130,0000.51%
CHARTWELL INVESTMENT PARTNERS, LLC 187,989$11,294,0000.37%
Stanley-Laman Group, Ltd. 24,000$1,442,0000.34%
GLOBEFLEX CAPITAL L P 18,751$1,127,0000.21%
Foundry Partners, LLC 70,357$4,227,0000.16%
View complete list of EAGLE PHARMACEUTICALS INC shareholders